Borviz 2 Mg

Borviz 2 Mg Specification

Indication
Multiple myeloma and mantle cell lymphoma

Brand Name
BORVIZ 2

Origin of Medicine
India

Pacakaging (Quantity Per Box)
1 Vial per box

Dosage Form
Lyophilized powder for injection

Life Span
Refer to pack for expiry

Salt Composition
Bortezomib

Packaging Type
Vial

Drug Type
Allopathic

Ingredients
Bortezomib

Physical Form
Injection

Function
Anticancer (proteasome inhibitor)

Recommended For
Patients requiring Bortezomib for therapeutic use

Dosage
2 mg per vial (as directed by physician)

Dosage Guidelines
For intravenous injection, single use only, as prescribed

Suitable For
Adults

Quantity
2 mg

Storage Instructions
Store below 25C, protect from light

Prescription Required
Yes

Route of Administration
Intravenous

Administration
For single use only

Reconstitution
Requires dilution before intravenous injection

Color of Packaging
White and purple

About Borviz 2 Mg

Order today and experience the stellar efficacy of BORVIZ 2 Mg, the laureate of anticancer therapy. Offered at the best price for a limited time, this immaculate lyophilized powder contains Bortezomib for intravenous injection, specifically designed for hospital and clinical use. Each vial holds 2 mg of potent Bortezomib, ensuring precise, prescription-only treatment for adults battling multiple myeloma or mantle cell lymphoma. Packaged in India, this single-use, allopathic injection should be stored below 25C and protected from light for optimal integrity-consult the expiry on the pack.

Therapeutic Application and Usage of Borviz 2 Mg

Borviz 2 Mg is used exclusively for hospital and clinical purposes, adhering strictly to prescription-only administration. Indicated for adults, it is primarily applied in the treatment of multiple myeloma and mantle cell lymphoma. This injection serves as a vital component in the management of these complex malignancies, crafted to deliver immaculate and reliable performance when administered intravenously by healthcare professionals, as per physician's guidance.

Borviz 2 Mg Availability, Distribution, and Certifications

Borviz 2 Mg is available for sample requests to eligible healthcare providers, ensuring confident purchasing decisions. The main domestic market spans across India, where distribution is handled through premium goods transport services for efficient and safe delivery. The product's certifications further underscore its commitment to quality, supporting hospitals and clinics in acquiring this essential anticancer treatment at a compelling sale price during promotional periods.

FAQ's of Borviz 2 Mg:

Q: How should Borviz 2 Mg be administered for optimal results?

A: Borviz 2 Mg must be administered as a single-use intravenous injection by trained medical personnel in a clinical or hospital setting, strictly following the dosage instructions provided by the attending physician.

Q: What storage conditions are recommended for Borviz 2 Mg?

A: The vials should be stored below 25C and protected from light to preserve the product's stability and effectiveness. Always refer to the package for the expiry date and additional storage guidelines.

Q: When is Borviz 2 Mg typically prescribed?

A: Borviz 2 Mg is prescribed for adult patients diagnosed with multiple myeloma or mantle cell lymphoma. Usage is determined by a healthcare professional based on the patient's specific therapeutic requirements.

Q: Where can Borviz 2 Mg be sourced and delivered?

A: Borviz 2 Mg is supplied and transported via premium distribution channels throughout India, primarily targeting hospitals and licensed clinics. Goods transport services ensure safe and timely delivery to healthcare facilities.

Q: What are the key benefits of using Borviz 2 Mg for patients?

A: This immaculate, laureate status injectable provides a targeted approach to cancer treatment, inhibiting proteasomes essential for tumor growth. This leads to improved therapeutic outcomes for patients combating certain hematological malignancies.

Get Latest Price